Pediatrix Medical Group Files 8-K on Shareholder Votes
Ticker: MD · Form: 8-K · Filed: May 9, 2024 · CIK: 893949
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: MD
TL;DR
Pediatrix (MD) filed an 8-K for shareholder votes on 5/9. Details TBD.
AI Summary
Pediatrix Medical Group, Inc. filed an 8-K on May 9, 2024, to report on matters submitted to a vote of its security holders. The filing does not detail the specific proposals voted on or their outcomes, but it confirms the date of the report and the company's principal executive offices in Sunrise, Florida.
Why It Matters
This filing indicates that Pediatrix Medical Group held a shareholder meeting where votes were cast on important company matters, the details of which are typically disclosed in subsequent filings or proxy statements.
Risk Assessment
Risk Level: low — This is a routine 8-K filing to report on shareholder votes, not indicating any immediate financial distress or significant operational change.
Key Numbers
- 001-12111 — SEC File Number (Identifies the company's registration with the SEC.)
- 26-3667538 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Pediatrix Medical Group, Inc. (company) — Registrant
- May 09, 2024 (date) — Date of Report
- Sunrise, Florida (location) — Principal Executive Offices
- MEDNAX, INC. (company) — Former Company Name
- PEDIATRIX MEDICAL GROUP INC (company) — Former Company Name
FAQ
What specific matters were submitted to a vote of Pediatrix Medical Group's security holders on May 9, 2024?
The filing does not specify the exact proposals voted on, only that matters were submitted to a vote.
What was the outcome of the shareholder votes reported in this 8-K?
The filing does not disclose the results of the shareholder votes.
Where are Pediatrix Medical Group's principal executive offices located?
The principal executive offices are located at 1301 Concord Terrace, Sunrise, Florida, 33323.
Has Pediatrix Medical Group changed its name previously?
Yes, the company was formerly known as MEDNAX, INC. (name change effective 20090102) and PEDIATRIX MEDICAL GROUP INC (name change effective 19950801).
What is the SEC file number for Pediatrix Medical Group?
The SEC file number is 001-12111.
Filing Stats: 621 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-05-09 16:30:37
Filing Documents
- md-20240509.htm (8-K) — 97KB
- img260268868_0.jpg (GRAPHIC) — 309KB
- 0000950170-24-057093.txt ( ) — 972KB
- md-20240509.xsd (EX-101.SCH) — 23KB
- md-20240509_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On May 9, 2024, Pediatrix Medical Group, Inc., a Florida corporation ("the Company"), held its 2024 Annual Shareholders' Meeting (the "Annual Meeting"). Of the 84,025,983 shares of common stock outstanding and entitled to vote, 77,537,611 shares were represented, constituting a quorum. The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2025 Annual Shareholders' Meeting or until their respective successors are elected and qualified, by the votes set forth in the table below: Name One Year Against Abstained Broker Non-Vote Laura A. Linynsky 73,432,501 1,509,624 43,525 2,551,961 Thomas A. McEachin 73,369,011 1,572,130 44,509 2,551,961 Mark S. Ordan 72,937,466 2,004,446 43,738 2,551,961 Michael A. Rucker 73,261,971 1,679,655 44,024 2,551,961 Guy P. Sansone 72,793,352 2,148,985 43,313 2,551,961 John M. Starcher, Jr. 73,449,095 1,492,773 43,782 2,551,961 James D. Swift, M.D. 74,088,894 862,285 34,471 2,551,961 Shirley A. Weis 72,600,050 2,343,090 42,510 2,551,961 Sylvia J. Young 73,458,297 1,484,944 42,409 2,551,961 Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2024 fiscal year was ratified by the Company's shareholders, by the votes set forth in the table below: For Against Abstained Broker Non-Vote 75,157,432 2,356,419 23,760 0 Proposal 3: The Company's shareholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the 2023 fiscal year, by the votes set forth in the table below: For Against Abstained Broker Non-Vote 71,662,763 3,286,998 35,889 2,
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pediatrix Medical Group, Inc. Date: May 9, 2024 By: /s/ C. Marc Richards C. Marc Richards Chief Financial Officer